Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

Researchers and physicians have grappled with the role of "adjuvant," or post-surgery, chemotherapy for patients with early-stage colon cancer, even for cancers considered high risk. Now researchers ...

Haystack MRD test detects minimal residual disease in stage 2 colorectal cancer patients post-surgery, using circulating tumor DNA (ctDNA) for less invasive monitoring. The FDA's breakthrough device ...

Circulating tumor DNA (ctDNA)—genetic material shed from tumors into the bloodstream—may help risk-stratify patients with Stage 3 colon cancer by tailoring chemotherapy options after surgery based on ...

Meta analysis in obese colorectal cancer patients found robotic assisted surgery modestly reduced hospital stay versus ...

Circulating tumor DNA (ctDNA) — genetic material shed from tumors into the bloodstream — may help risk-stratify patients with Stage 3 colon cancer by tailoring chemotherapy options after surgery based ...